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1. Introduction 
Improvement in health care has lead to increased life expectancy through the chronicization 
of formerly fatal diseases. On the other hand, increasing duration of exposure to risk factors 
means that the incidence of lung cancer increases in proportion to age, and is actually the 
first cause of death for malignancy in the world. 
Consequently, a growing number of very elderly people, aged 80 or more, are presenting 
with a resectable lung tumour. The increased prevalence of cardiovascular and pulmonary 
comorbidity and consequently poor performance status often make patients unfit to 
surgery, which remains the treatment of choice for early stages Non-Small Cell Lung Cancer 
(NSCLC) [1, 2]. Increasing age is often associated with lower likelihood of treatment and 
more liberal use of radiation therapy than of surgery [3]. 
1.1. Background 
In a recent paper Janssen and Kunst found that in 2050 predicted life expectancy for people 
reaching 80 years will be 9.16 years for men and 12.65 for women [4], which clearly 
overcome the prognosis of lung cancer. Therefore, cancer-related mortality will likely have a 
even more great impact on octogenarians survival. 
Although several studies have shown that long term survival after surgery can be achieved 
in a significant proportion of octogenarians. However the minimal prognosis of untreated or 
palliated early stage lung cancer (1.5 years) forces to go beyond palliative cares [5]. 
Recently, even more Authors reported results after surgery in very elderly patients: 
unfortunately many studies consist of retrospective, non-randomized studies on small 
number of patients making difficult to define risk factors for complications and mortality. 
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Considering the improvement in preoperative functional assessment, anaesthetic care, pain 
relief, postoperative facilities and modern surgical techniques, it is possible that more 
octogenarians could be successfully operated, but an accurate selection of patients is 
mandatory to avoid excessively high incidence of complications and mortality. Moreover long 
term results such as respiratory function and quality of life (QOL) is as well as important in 
decision making process to schedule or deny surgery: even less data are available in this field, 
particularly comparing surgery to medical therapies (chemo- and radiotherapy). 
Established that surgery is undoubtedly the best therapy for early stage lung cancer to date, 
especially in terms of local control of disease, this chapter aims to analyse short 
(complications, mortality) and long-term (respiratory function) of very elderly people. 
Analysing results in a large cohort of patients and reviewing literature we try to suggest 
proper selection criteria to surgery in these patients, considering risk/benefit of alternative 
treatment modalities. 
2. Report of a single institution experience 
My colleagues and I reported some years ago our results in a large series of octogenarians 
consecutively operated on between January 1990 through December 2005 [6]. Life 
expectancy in the province is greater than the national average and octogenarians have 
always represented a significant percentage of patients with resectable lung cancer. 
2.1. Material and methods 
The lung cancer database of a single centre (Thoracic Surgery Unit at the University 
Hospital of Siena) was retrospectively reviewed to identify all patients aged >= 80 years who 
underwent lung resection for NSCLC with curative intent in the period considered above. 
We tried to limit the period of study to 1990, mainly because the very few octogenarians 
treated before 90’s and secondly to eliminate bias due to patients selection, clinical staging 
and functional assessment through decades. 
All patients were extensive evaluated throughout medical history, physical examination, 
routine blood tests, electrocardiogram, echocardiography, blood gas analysis, spirometry 
and calculation of diffusion capacity of the lung for carbon monoxide (DLCO). Second level 
tests were performed when indicated: cardio-respiratory test and/or lung perfusion 
scintigraphy in case of poor pulmonary function at basal spirometry (predicted post-
operative FEV1% less than 40%, computed on the basis of pulmonary segments to be 
removed); cardiac stress tests and eventually coronary angiography were performed in 
presence of clinical symptoms of angina pectoris, significant ischemic signs at basal 
electrocardiogram, or segmental cardiac discinesia at basal echocardiography. 
Clinical staging was based on chest CT-scan, bronchoscopy, CT-scan of chest, abdomen and 
brain and bone scintigraphy. Mediastinoscopy was electively performed in case of enlarged 
mediastinal lymphnodes at CT scan (short axis > 1 cm) with irregular pattern of post-
contrast perfusion. PET was not routinely used due to unavailability in the hospital of Siena 
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but was performed in the last seven consecutive patients resulting positive only in the site of 
primary tumour. Whenever possible, a preoperative diagnosis was done, even by 
transpleural methods (Fine Needle trans-thoracic Aspiration - FNA). 
Indication to surgery was established on the basis of features of disease (determining 
resectability), and features of the patient (determining operability). Efforts spent to achieve 
accurate preoperative staging were finalized to select early clinical stages (I-II). Operability 
of the patients was judged in a multidisciplinary setting including pneumologist and 
anaesthesiologist. Decision was based on functional status and comorbidities: we did not 
considered an age-limit as a contraindication per se to surgery. Our surgical policy favoured 
lobectomies over sublobar resections and whenever possible we tried to avoid 
pneumonectomy. Sublobar resection was preferred by the attending surgeon in case of poor 
respiratory function and/or severe cardiovascular comorbidities, and was considered a 
compromise: anatomical segmentectomies were however preferred to wedge resections and 
were considered adequate for stage I peripherally located tumours. 
None of the patients received neoadjuvant therapy for at least two reasons: first, patients in 
advanced clinical stages (III or IV) were denied to surgery in favour of low dose chemo or 
radiation therapy and best supportive care; second, postoperative risk of major lung 
resection after induction chemotherapy was judged excessively high in such patients 
Adjuvant therapy was administered in case of unforeseen lymph nodal disease or residual 
disease. Radiotherapy was preferred, although 4 patients in very good health conditions 
could tolerate chemotherapy. 
Postoperative complications were classified as minor (non life-threatening) or mayor 
(potentially life-threatening), according to gravity of the disease and its mortality in 
literature and in our population. 
Data recorded included demographic and clinical features of population (gender, age, 
smoking history, performance status, preoperative pulmonary function tests, comorbidities, 
use of induction therapies), as well as perioperative data (type of lung resection, operative 
mortality - defined as death within 30 days from surgery or during the same hospitalization, 
complications, length of in-hospital stay, admission to ICU, histology, pathologic stage and 
the use of adjuvant therapy. 
Follow up included total-body CT scan and serum cancer markers every 6 months for first 2 
years, then chest CT scan every 12 months until the fifth years. Bronchoscopy and recently, 
PET-scan were performed only in case of suspected local or distance recurrent disease. 
Deaths included all causes but we differentiated only cancer and non-cancer related deaths. 
Binary logistic regression analysis was used to discriminate independent risk factors for 
mayor complications and 30-days mortality after surgical resection. Long term survival 
curves were computed by the Kaplan-Meier method and compared with Log-rank test. Cox 
regression analysis was used to determine significance of prognostic factors for long term 
survival. 
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2.2. Results 
In the period considered, 96 octogenarians affected by NSCLC underwent surgery with 
curative intent (5.6% of 1711 lung resections performed during the same period). 
Over the years an increase of percentage of octogenarians having a pulmonary resection for 
NSCLC was observed (from 2.7% in 1990 to 14% in 2005): it reflects the considerations 
expressed above and it is likely that there will be a growing trend of such percentages in 
next years. 
Population was predominantly male (84), with age ranging from 80 to 89 (median, 82 years). 
Data of population is shown in Table I: some of the data are worthy of note: almost all 
patients (90%) had a history of cigarette smoking with 40 median pack-years and almost half 
of them (48.9%) presented comorbidities, mainly cardiopulmonary. Thirteen patients had a 
history of coronary artery disease, defined as a history of prior myocardial infarction, prior 
coronary stenting or by-pass or angina pectoris. Despite this percentages, almost all the 
octogenarians (94 – 97.9%) were Eastern Cooperative Oncology Group (ECOG) status 0 or 1. 
The surgical procedures performed included 59 standard lobectomies, 4 extended 
lobectomies, (one upper sleeve lobectomy, 3 en block chest wall resections), 13 wedge 
resections (2 performed by VATS), 9 pneumonectomies, 7 segmentectomies and 4 
bilobectomies. Patients with pO2<65 mmHg or a pCO2 >45 mmHg and/or MVV or an FEV1< 
50% of predicted were scheduled for sublobar resection. 
The histological examination of the resected specimens revealed NSCLC in all patients: one 
of the aims of preoperative histological biopsy was to exclude histology with proven poor 
survival (small-cell carcinoma). 
Regarding pathologic stage, 61 (63,5%) patients were confirmed to be in stage IA or IB: 
concordance with clinical staging was not so high but it should be taken into account 
unavailability of modern diagnostic tools for staging. Adjuvant chemotherapy was 
administered in 6 patients and radiotherapy in 2 patients due to unforeseen pathological N2 
disease or unexpected residual microscopic disease. 
One or more complications developed in 42 patients for a total morbidity of 44%. Five 
patients suffered multiple complications. Mayor complications lead to death 9 of 17 patients 
(52.9%) resulting in an overall mortality rate of 9.4% (Table 2). 
The median postoperative hospitalization was 8 days, not significantly longer than in 
younger patients (7 days) although 7 patients were discharged after more than 2 weeks. 
Eighty patients (83%) were discharged home without need of further rehabilitation; only 10 
patients (9.6%) were discharged to a convalescent care facility. 
It must be underlined that no patient suffered permanent or prolonged disability after lung 
resection although post-thoracotomy pain syndrome was present in a small percentage after 
several months (14% after 1 year), causing significant discomfort. 
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Mean age (years) 81.5 ± 1 
Sex (M/F) 84/12 
Smokers 86 (90%) 
Comorbidities 47 (49%) 
> 1 comorbidity 13 (13.5%) 
Respiratory parameters  
FEV1 (% of predicted)  75.8% ± 16.2% 
CO diffusion (% of predicted)  76.5% ± 20.7% 
PaO2 (mm Hg) 75.1 ± 11.4 
Pathological stage  
I 61 (63.5%) 
II 17 (17.7%) 
III* 17 (17.7%) 
IV§ 1 (1%) 
Surgical procedure  
Lobectomy 68 (70.8%) 
Sublobar resection 19 (19.8%) 
Pneumonectomy 9 (9.4%) 
Extended resection  
Bilobectomy 4 (4.2%) 
En-bloc resection with chest wall 3 (3.1%) 
Histology  
Adenocarcinoma 42 (43.8%) 
Squamous cell carcinoma 48 (50%) 
Adenosquamous carcinoma 2 (2.1%) 
Large cell carcinoma 4 (4.2%) 
Comorbidities  
Coronary artery disease* 13 (13.5%) 
Chronic obstructive pulmonary disease 19 (19.7%) 
Vascular disease 13 (13.5%) 
Diabetes mellitus 8 (8.3%) 
Chronic atrial fibrillation 4 (4.1%) 
Heart valve disease 3 (3.1%) 
Kidney failure 1 (1%) 
FEV1 = forced expiratory volume in 1 s. 
* N2 disease in 12 cases and T3N1 disease in 5 cases 
§ contralateral pulmonary metastasis 
Table 1. Demographic, clinical, and pathological data of patients 
 Current Concepts in General Thoracic Surgery  46 
Major complications N. (%) 30-day mortality (%) 
Respiratory failure 3  
ARDS 3 3 
Broncho-pleural fistula 2 2 
Cardiac failure 2 1 
Kidney failure 1  
Pneumonia 1 1 
Pulmonary embolism 1  
Stroke 1 1 
Pulmonary edema 1  
Hematemesis 1  
IMA 1 1 
 17 (17,7) 9 (9) 
Table 2. Major complications rate and mortality 
Using binary logistic regression analysis, among the pre- and peri-operative covariates 
analyzed, we found that resection of more than 1 lobe (p=0.008), cardio-respiratory 
comorbidity (p=0.042), PaO2<75 mmHg (p=0.029) and DLCO<60% (p=0.023) were predictive 
of major complications with the first risk factor predicting 30-day mortality too (p=0.01). 
Detailed results are reported in Table 3 and 4. 
 
Covariate RR 95% CI p 
Extended resection* 10.5 1.9–59.7 0.008 
Comorbidity 5 1.06–24 0.042 
FEV1 < 60% 0.45 0.08–2.5 0.36 
CO diffusion < 60% 6.24 1.28–30.37 0.023 
PaO2 < 75 mm Hg 5.42 1.19–24.65 0.029 
Age 0.7 0.46–1.04 0.076 
Sex 0.17 0.014–2.21 0.18 
*Bilobectomy, pneumonectomy, or en-bloc chest wall resection. CI = confidence interval, FEV1 = forced expiratory 
volume in 1 s, RR = relative risk. 
Table 3. Predictors of major postoperative complications 
 
Covariate Value RR 95% CI p 
Extended resection 12.96 1.85–90.89 0.01 
Comorbidity 6.69 0.69–64.69 0.1 
FEV1 < 60% 1.59 0.2–12.87 0.66 
CO diffusion < 60% 3.97 0.52–30.61 0.18 
PaO2 < 75 mm Hg 1.08 0.18–6.36 0.93 
Age 0.78 0.47–1.31 0.36 
Sex  1.15 0.08–17.36 0.91 
Table 4. Predictors of 30-day postoperative mortality 
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At the mean follow-up of 42 months (range 8 months to 12 years), 46 (47.9%) patients were 
alive and 50 (52%) had died. 
It was surprising that, despite the advanced age, the majority of patients (29/50, 71%) died of 
cancer, either by local recurrence or distant metastasis. 
The 5-year survival rate was significantly different between stage I and stage III (60%vs14%, 
p<0.001) and between stage II and stage III (42%vs14%, p=0.046). There was no statistical 
difference in 5-year survival rate between stage I and stage II (p=0.39). The overall 3- and 5-
year survival rates were 51% and 34%, respectively, with a median survival of 3.7 years 
(95% CI, 2.7 to 4.6 years) (Figure 1). 
 
Figure 1. Actuarial survival according to pathological stage. 
Using the Cox proportional hazard model of multivariate analysis, only pathological stage 
of disease resulted as an independent predictor of long term survival (p=0.003): stage II or 
more carries a relative risk of 4.2 to die of disease (Table 5). 
 
Covariate RR 95% CI p 
Pathological stage (II-III Vs I) 4.2 1.74–10.46 0.001 
Extended resection 1.2 0.37–3.6 0.81 
Comorbidity 16.4 1.1–237.5 0.38 
FEV1  1 0.97–1.03 0.87 
DLCO 1 0.98–1.02 0.56 
PaO2 0.95 0.95–1.2 0.295 
Age 0.97 0.79–1.2 0.81 
Sex 0.61 0.17–2.2 0.44 
Table 5. Predictors of long-term survival 
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2.3. Interpretation of results 
Although recent studies have demonstrated acceptable long term survival after lung cancer 
surgery in octogenarians [7, 8, 9, 10], elderly patients are less likely to have surgical resection 
[4], because advanced age is an important risk factor for postoperative complications and 
death, [1, 2]. In fact, despite an improvement in early outcome in the past ten years, the risk 
of life-threatening complications for octogenarians remains variable: Harvey et al., reported 
a 1.6% risk in patients 70-79 years old compared to a 17.6% rate in octogenarians [11] and 
Naunheim et al. [12] reported that even within the octogenarians, increasing age was a 
negative factor. 
The 9.4% operative mortality observed in this series is similar to other reports covering the 
same time period [13] but was exceedingly higher in patients who required an extended 
resection (more than one lobe or chest wall and lung en bloc resection), as found also by 
other Authors. [14, 15]. 
The mortality rate after pneumonectomy and even after bilobectomy was remarkable: 22% 
and 25%, respectively: it is well known that operative mortality is substantial in elderly 
people having extended resection, especially right sided pneumonectomy, with mortality 
exceeding 20% [1, 16, 17]. Besides, the British Thoracic Society noted that pneumonectomy is 
associated with a higher mortality risk in the elderly and that age should be a factor in 
deciding suitability for pneumonectomy. 
These results convinced us to consider for surgical operation only octogenarians with lung 
cancers amenable to be resected by lobectomy. In addition, also pulmonary resections 
combined with en bloc chest wall removal should be avoided since they carry an increased 
mortality rate as previously reported by [2, 18]. The mortality rate was instead acceptable 
after standard lobectomy (8.4%, result in line with those reported in literature) and was null 
after wedge resection or segmentectomy. 
We observed 17 major complications (mainly cardiopulmonary) in 16 patients, and is note 
worthy that they lead to death in more than half of the cases (9/17, 52.6%). 
Cardiac complications developed frequently during the postoperative period. All patients 
had an echocardiogram but exercise stress testing was only executed in case of symptomatic 
angina, history of infarction or ECG abnormalities. The efficacy and cost-effectiveness of 
exercise stress testing or dipyridamole thallium scan as screening tests is controversial, but 
probably we should use a lower threshold for these second- and third-level investigations in 
the octogenarians. When they result positive, it is useful to proceed to coronary angiography 
because patients found to have significant coronary lesions amenable to angioplasty, can be 
successfully operated on after 2 months (3 cases in our experience). On the other hand, if 
coronary artery bypass surgery would be required, we prefer to manage the patient 
nonoperatively with radiotherapy, because we believe that combined heart-lung surgery 
carries an excessive risk in advanced age people [19]. 
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Long term survival is also of critical importance in this patient population with limited 
natural life expectancy. 
Our overall 5-year survival of 35% is consistent with that reported in similar series over the 
past decade, with 5-year survival rates ranging from 16% to 55% [7, 8, 9, 10, 20, 21]. 
As expected pathologic stage was an independent prognostic factor for long-term survival 
but, differently from previous studies in the octogenarians except for one [14], our survival 
curves justify surgery also for patients with stage II NSCLC, with 5-year survival rate of 
42%. Survival in stage III disease is uniformly very poor in all the series and is significantly 
lower than in the younger counterparts, probably because a fewer percentage of older 
patients are able to tolerate extended surgical procedures and complete multimodal 
treatments. A recent report of Fanucchi and coll. reported a low 5-years survival: Authors 
correctly recognized that it was due to unexpected high incidence of stage III disease 
because of inaccurate clinical staging [22]. 
The QOL and the level of independence after surgery should be a major component in the 
decision-making process in the elderly. 
We did not identify any prolonged disability and the fact that nearly 80% of octogenarians 
in this cohort were discharged directly to home suggests that most patients were able to 
resume the preoperative lifestyle. 
3. Lung volume reduction era and its importance in lung cancer surgery 
In the late 1950s, Brantigan and co-workers were the first to present the modern concept of 
lung reduction for emphysema, theorizing that by surgically reducing lung volume, part of 
circumferential pull upon the bronchioles could be restored, diaphragm could be brought 
higher with more efficient function and size of the thoracic cage could be reduced, allowing 
for better contraction of the intercostal muscles and ultimately reducing airflow obstruction 
and relieving dyspnoea [23]. Further results confirmed efficacy of lung volume reduction 
surgery (LVRS), with outcome improving parallel to refinement of selection criteria, 
although long-term survival did not seem to be positively affected as symptoms and 
pulmonary function.  
Because lung cancer and emphysema share common risk factors, it is not surprising to find 
that both conditions are often seen in the same individual as stated in the text. First papers 
addressing combined adequate cancer resection with volume reduction were published only 
in 1998 and were based on very small series of patients (5 and 14): all of them did well 
postoperatively and showed long term benefits in dyspnoea index, FEV1, and 6-minute 
walk test [24, 25]. 
In the evaluation of patients candidate for surgery, spirometry is still considered the gold 
standard: ppoFEV1% is the most powerful predictor of medical postoperative mortality and 
morbidity as demonstrated by Kearney and coll. [26]. The second-level assessments as 
inhalation-perfusion lung scintigraphy and cardio-respiratory exercise test may be useful in 
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further evaluation of “critical” patients: however, while they demonstrated valid predictors 
of postoperative complications, they did not clearly show a higher accuracy than simple 
ppoFEV1% obtained by calculation of broncho-pulmonary segments removed [27]. 
McKenna and coll. [28] reported in 1997 that improvement in poFEV1% and dyspnoea score 
was more evident in patients aged under 70, although the differences were not statistical 
significant. A growing number of studies in the recent years have reported an improvement 
of respiratory function after lobectomy in some patients affected by COPD [29], or at least a 
minimal impairment of respiratory function indicated by better apoFEV% (actual 
postoperative) than ppoFEV1% (predicted postoperative)[30]. In such cases Authors have 
hypothesized that lobectomy could have a lung volume reduction surgery (LVRS) effect 
[31].  
This data from literature suggested us that even elderly patients with less severe COPD 
could get some benefit from resection of emphysematous parenchyma and therefore in the 
decision making process that lead to schedule an octogenarian to lung surgery, additional 
considerations should be made in evaluating respiratory function: not only preoperative 
FEV1% but also ppoFEV1% could be inaccurate in some cases in predicting the real 
postsurgical pulmonary function loss. Moreover, other studies reported that abnormal 
pulmonary function (FEV1%<60%) was not associated with mortality [20, 7, 10], with only 
first study reporting higher incidence of complications. 
Curative surgery chance to octogenarians affected by emphysema and lung cancer is 
therefore to be seriously considered. 
4. Long term respiratory function in our series 
A previous study conducted Thoracic Surgery Unit at University Hospital of Siena on 
patients who underwent pneumonectomy demonstrated that a lower preoperative 
respiratory function was associated to a much lower loss after pneumonectomy [32]: these 
data, together with some comforting results of bilateral LVRS procedures performed by 
VATS in the same Institution, stimulated us to analyzed late variation of respiratory 
parameters in the same cohort of octogenarians presented above. Results were published in 
2011 [33]. 
4.1. Materials and methods 
In order to analyze a subgroup as more homogeneous as possible, we considered only 
patients with COPD (defined by a Tiffenau index < 0.7). Since sublobar resections 
demonstrated to be well tolerated by elderly patients and resection of more than 1 lobe or 
combined chest wall resection is not recommended (being associated to major complications 
and in-hospital mortality) we limited analysis to standard lobectomy. Patients who received 
adjuvant therapies (anyway a small number) and those who continued smoking were 
excluded in order to eliminate bias. Spirometry was not routinely repeated at predetermined 
time and it was decided to consider patients with spirometry executed after 12±3 months 
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from surgery (in absence of local relapsing disease or exacerbation of COPD). Pulmonary 
Function Test (PFT) were performed after bronchodilator inhalation in order to eliminate the 
reversible component of airflow impairment Out of the 96 patients 24 fulfilled all inclusion 
criteria and formed the population of the study. 
Obviously removing non-functioning lung tissue does not affect pulmonary reserve, 
however no patients presented atelectasis or obstructive pneumonia of lobe to be resected. 
Predicted Postoperative FEV1% (ppoFEV1%) was computed not simply on the basis of 
crude amount of segments to be resected: the attenuation value of lung parenchyma 
(between -600 and -900 Houmsfield Unit) was used to compute the percentage of 
functioning tissue resected and to correct the predicted-postoperative FEV1, as proposed by 
WU et al [Wu 1994]. This method had been demonstrated to be a valid substitute of lung 
perfusion scintigraphy, with a good correlation of values found by the two methods 
[Yoshimoto 2009]; however in patients with worst respiratory impairment (FEV1<60%) lung 
perfusion scintigraphy was executed and used to compute ppoFEV1. 
Roentgenographic pattern of emphysema (homogeneous Vs upper lobe) was established 
according to criteria proposed by Goddard and coll. for CT-scan [34]; data were analyzed 
using unpaired Student t-test for comparison of means of continuous variables between 
groups, paired t-test was used to assess differences within groups between preoperative and 
postoperative values.  
4.2. Results 
Patients were categorized into two groups (Group 1: moderate COPD; Group 2: mild COPD) 
according to the Global initiative for chronic Obstructive Lung Disease (GOLD) criteria [35]: 
Group 1 (G1) FEV1% < 80%; Group 2 (G2) FEV1% ≥ 80%). The threshold value coincided 
with median FEV1% of population, making the two groups equal in terms of number of 
patients. 
There was no difference in gender, age, pathologic stage, comorbidities and histology 
between the two groups, nor in incidence of major complications (15% Vs 12% - p=0.72) and 
postoperative ECOG status Considering the whole population (96 patients) which this series 
of patients came from, overall perioperative and in-hospital death was 6.5% in Group 1 and 
11.5% in Group 2 (p=0.35). 
Comparing preoperative and postoperative PFT values in both groups, FVC% and RV%, 
showed significant variations. In G2 a significant loss in DLCO was registered. Interestingly 
the FEV1% loss was statistically significant only in G2 (88.3 to 73.7, p<0.001): in G1 FEV1% 
loss was much less remarkable, decreasing from a mean value of 67.8 to 59.1 (p=n.s.). 
Variation of FEV1% between the two groups after surgery was -7.9% in Group 1 and -14.9% 
in Group 2, showing a tendency to significance (p=0.17); also differences in FVC% between 
the two groups were not remarkable (-13.3% in Group 1 and –6.7% in Group 2 – p=0.33). 
DLCO% loss was much higher in G2 than in G1 (-22.5 Vs +1.5, p=0.001). 
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Six patients showed an improvement of actual postoperative FEV1%, ranging from +1.5 to 
+7.3 compared with the preoperative value. All of these patients had a preoperative FEV1% 
lower than 60%, a homogeneous or upper lobe pattern emphysema as confirmed by both 
CT-scan and/or lung perfusion scintigraphy (when available) and had undergone a upper 
lobectomy. Type of lobectomy had no influence in FEV1% loss in G2 (upper lobectomy: -
14.5% - lower lobectomy: -15.6%, p=0.81), as it demonstrated to have in G1 (upper 
lobectomy: +5.4% - lower lobectomy: -14.5%, p=0.05). (Figure 2). 
 
Figure 2. Variations of FEV1% after surgery in the two groups (mean, standard deviation, range), 
stratified for type of resection (upper Vs lower lobe) 
Considering FEV1 as a continuous variable, linear regression analysis showed a significant 
inverse correlations between preoperative value of FEV1% and FEV1 percentage loss after 
surgery (B: -0.63, R2: 0.46 – p<0.01), even though linear correlation does not represent 
effectively the complex physiopathology following lung resection in patients with 
COPD/emphysema. 
Blood gas tests reflected in some way the variations of PFT parameters: in G1 the lower loss 
in respiratory function resulted in not significant difference in PaO2, PCO2 and pH before 
and after surgery. Conversely patients in G2 showed a significant PaO2 decrease after 
surgery. No differences were found between the two groups at time of follow-up. 
4.3. Interpretation of results: does LVRS effect act also in octogenarians? 
Patients of this series obviously did not accomplish completely the criteria for LVRS and on 
the other hand apical wedge resection (and not lobectomy) is the recommended surgical 
option for lung volume reduction. Lobectomy implies removal of functioning lung tissue, 
together with emphysematous one, and this can explain the significant FVC% loss in G1: 
this is not observed after LVRS performed in properly selected candidates. However, some 
physiological effects of LVRS remain and are responsible of the remarkable drop of RV% 
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and the not significant loss in FEV% after surgery in G1: DLCO showed a gain of +1.5 at 
follow-up, probably due to more correct redistribution of ventilation and perfusion in lung 
zones. Patients in G2 having better pulmonary function, had the major impairment (of 
FEV1% and also DLCO%), because of the resection of a major portion of functioning lung. 
This results confirmed previous reports [36]. 
It must be noted that most of these studies report functional results after 1, 3 or 6 months: at 
this time, the post-thoracotomy pain could be still present in some cases, maybe causing a 
restrictive pattern and consequently a bias of the results [37]. In our series, all patients 
received a postero-lateral muscle-sparing thoracotomy, reducing a possible factor 
conditioning the amount of thoracic pain. 
The functional advantage after an upper lobectomy than a lower lobectomy in patients with 
higher airflow impairment (G1) probably simply reflects predominantly upper lobe 
emphysema (as usual observed); however the same physiopatologic considerations should 
be valid in any case of resection of more emphysematous - less functioning lung lobe 
although no data can be provided supporting this consideration. 
It should be kept in mind that PFTs are conditioned by patients collaboration and represent 
a kind of “surrogate” of effort tolerance which do not necessarily correlate with values 
measured at a single time. However postoperative global performance status and exercise 
tolerance seemed to reach a similar level in both mild and moderate COPD patients (G1 and 
G2), supporting the conclusion that differences in functional status are levelled after a major 
lung resection. 
Although some limitations due retrospective nature of the study, and possible presence of 
bias such as the preoperative optimization of respiratory reserve through medications 
and/or physical rehabilitation, we tried to select an homogeneous cohort of patients with 
strict inclusion criteria in order to establish the pure effect of lobectomy after a long time, 
enough to allow remodelling processes of lung and thoracic wall until the final steady 
result. The inadequacy of sample size often did not allow to reach statistical significance in 
some tests. Lung perfusion scintigraphy was not routinely performed, so we had to use CT-
scan estimation method as surrogate to obtain corrected ppoFEV1. 
Finally the retrospective nature of the study itself implies that some patients were denied 
surgery resulting, for example, in unavailability of data for patients with lower preoperative 
FEV1 and homogeneous pattern of emphysema undergone to lower lobectomy, so the 
benefit of upper lobectomy could be deducted only on physiological basis. 
5. Surgery – RT 
Since chemotherapy is not well tolerated by elderly people and yields very disappointing 
results in local control of disease, radiation therapy (RT) has ever been considered the most 
feasible and valuable therapeutic option in patients not fitting criteria for operability. 
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Consequently, literature reports several series of patients treated with RT. In an old report 
dated 1988, results on 50 patients not candidate to surgery with peripherally located stage I 
NSCLC were analyzed: the overall response rate was 90%, with 50% complete responses in 
tumors smaller than 4 cm, resulting in overall survival rates of 56% at 2 years and 16% at 5 
years (median survival of 27 months). Complete responders (20/50) showed a remarkable 5-
years survival of 42% with 25% of local relapse of disease. On the contrary none of the 
patients having a tumor greater than 4 cm was alive at 5 years. Results were favorable 
compared to those of a group of 70 patients surgically resected (median survival of 23 
months). 
The same positive results were reported several years later in a larger series of 347 patients: 
curiously, better results were achieved in elderly people (aged > 70), although the difference 
was not significant, in terms of crude survival and disease-free survival [38]. Other Authors 
reported worse results of RT compared to surgery, with 5-year survival rate of only 10 to 
20% after curative intent radiotherapy [39]. 
Unfortunately, very few studies report results of surgery and RT in the same Institution, 
most of them being retrospective and non-randomized. 
Yendamuri compared overall survival after surgery (wedge resection) and three 
dimensional conformation radiation therapy in a retrospective study on 160 patients with 
early stage lung malignances unable to tolerate lobectomy.  Propensity score-matched 
analysis and cost assessments were performed to compare outcomes with both modalities. 
Propensity matching was also performed to assure homogeneity between arms in terms of 
gender, histology, tumor size, performance status, and age The most frequent long term 
complications encountered were post-thoracotomy pain syndrome and radiation 
pneumonia with pulmonary fibrosis. . Surgery arm showed a trend to improved outcome 
towards radiotherapy one (57,1 months Vs 40,9 months), while mean cost of radiation 
therapy ($32,735) was not statistically significantly different from surgery ($30,411). 
Propensity matched analysis however failed to confirm a clear benefit of sublobar 
pulmonary resections, and it could be explained by inadequacy of number of patients and 
other bias (retrospective – not randomized trial, increased comorbidities of patients treated 
with 3-D conformal radiation) [40]. 
In another smaller series of compromised patients (not suitable for lobectomy) 
retrospectively reviewed (17 treated by sublobar resections, either segmentectomy or wedge 
resection and 18 by radiation therapy alone) overall 5-years survival rates were 55% after 
surgery and 14,4% after radiation therapy (p=0.004), without significant more complications 
due to lung resections. The advantage in long-term survival was maintained even 
considering only total or partial responders among patients treated with radiation therapy 
(+18.8%, p=0.008). Even in this series complications reported did not differ between the two 
treatment modalities (11.8 compared to 11.1). Local recurrence at margins of resection 
occurred in 4 patients in which tumour diameter was greater than 2 cm. Authors concluded 
that surgery carries advantage over radiotherapy, especially for smaller lesions measuring 
less than 2 cm [41]. 
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A prospective analysis of QOL after radical radiotherapy noted benefit on haemoptysis, 
pain and anorexia, while cough, dyspnea and fatigue were poorly alleviated; also global 
QOL responded poorly [42]. 
6. Novel perspective for management of lung cancer in octogenarians 
6.1. Diagnosis – Staging 
Histological proven diagnosis is significant less frequent in elderly: this may reflect the poor 
perceived fitness of withstand bronchoscopy, CT guided biopsy and other invasive 
techniques [43]. 
Preoperative histopatological confirmation should preferably be obtained in elderly people 
to avoid unnecessary surgery for benign lesions or, to identify patients with poor prognosis 
related histology (small-cell carcinoma, large-cell undifferentiated neuroendocrine 
carcinoma).  
Trans-thoracic Ultrasound or CT guided Fine Needle Aspiration was found to have 
equivalent safety and tolerance to procedure in elderly patients (aged 70 or more), with 
majority of cases performed as a day-case [44]. 
In our series of patients, concordance of clinical and pathological staging was a not exciting 
63%: the use of sole CT-scan and blind transbronchial/trans-tracheal endoscopic fine needle 
biopsy has certainly played a role in understaging. The introduction of PET-CT scan in 
routine assessment for staging purpose in most Institution demonstrated to enhance 
conventional staging, both for nodal status and distant metastasis, resulting in a 10% of 
downstaging and 33% upstaging. This changed intent of treatment from palliative to 
curative in 4% and vice-versa in 22% of cases [45]. 
Endoscopic UltraSound guided Fine Needle Aspiration (EUS-FNA) performed by 
bronchoscopy by skilled operators promises to improve sensitivity in metastasis detection of 
PET positive lymph-nodes not necessarily increased in size (CT-scan nodal assessment is 
essentially based on dimensional criteria and post-contrast perfusion nodal pattern and is 
operator-dependent).  
A prospective study on 86 with mediastinal adenopathies provided impressive negative and 
positive predictive value (94% and 100% respectively). This allowed to shift to non-surgical 
management in 80% of cases [46]. 
6.2. Image Guided Radiotherapy/Intensity Modulated Radiation Therapy 
(IGRT/IMRT) 
This novel techniques promise to be a milestone in radiation treatment for capacity to 
delineate tumour contour and correct it for patients positioning, resulting in two theoretical 
high advantages compared to traditional radiation therapy. 
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1. Greater precision in irradiating tumour volume with minimal toxicity of neighbouring 
healthy tissues (lower incidence of side effects) 
2. Possibility to deliver higher dosage with presumed higher efficacy 
Unfortunately, despite this convincing rationale, literature lacks of robust studies to confirm 
promising clinical benefits. To date, there is enough evidence on technical performance, 
encouraging but not yet conclusive information on safety, very weak evidence in clinical 
effectiveness and none on cost-effectiveness. The proportion of patients with the clinical 
indications for IGRT/IMRT inferred by the RER (Regione Emilia Romagna) regional 
database result in an estimate 10% of all lung cancers (the lowest percentage among several 
solid tumours considered – brain, prostate, head and neck, pancreatic). 
Nonetheless IGT/IMRT are worthy to be seriously considered in future clinical trials, 
preferably involving a surgery arm. 
6.3. Minimally invasive surgery: VATS lobectomy 
Videothoracoscopic Assisted Thoracic Surgery has in recent years gained again popularity 
and has become of routinely use in some Institutions for early stages lung cancers not 
involving fissures of hilar elements. Octogenarians seem to have the proper characteristics 
for indication to VATS major resections. Firstly, as stated above, only patients with stage I-II 
tumours amenable to be resected by standard lobectomy should be operated on; secondly, 
advantages of VATS compared to thoracotomy (less postoperative pain, lenght of stay, 
functional impairment) are theoretically able to reduce complications and mortality in such 
frail patients.  
A recent study on 95 octogenarians who received surgery either by VATS (n=58) or standard 
thoracotomy (n=37) in a single Institution, demonstrated that major cardiopulmonary 
complications occurred in 13.8% of VATS group and 32.4% of open surgery group (p=0.03). 
Five-years survival was not affected but study was retrospective, non-randomized and 
suffers some bias in patients selection (more I stages in VATS group) [47]. However efficacy 
of VATS has been reported by several other Authors [48, 49]. It has been demonstrated that 
VATS surgery generates less cytokine production in early postoperative phase and less 
impairment of postoperative pulmonary function, which ultimately could decrease in-
hospital complications, as stated in the text. 
Therefore there is enough evidence to support minimally invasive surgery especially in very 
elderly people. 
6.4. Thermal ablation  
Thermal ablation has been shown to be effective as local treatment of solid tumours. The 
main modalities to achieve thermal damage of malignant tissue are radiofrequency (RF), 
microwave (MW) and cryoablation; all them are applied directly to tumour through 
different devices positioned percutaneously through an image-guided procedure.  
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Lung tissue has unique characteristics which maximizes the so called heat sink effect: airflow 
and bloodflow limits in fact the intended tissue damage, that results smaller in vivo versus 
in vitro experiments, acting as an air/liquid-cooled radiator. Lung has therefore a small 
thermal conductivity. 
In these regards MW has some theoretical advantages over RF ablation, because thermal 
damage is realized through electromagnetic waves that cause polar water molecules to 
rotate rapidly; MW is not limited by thermal and electric conductivity of tissue, reaching so 
larger zones and higher temperatures in lung [50]. Histopathological studies indicates that a 
margin of 8 mm for adenocarcinomas and 6 mm for squamous cell carcinoma are necessary 
to cover 95% of microscopic disease [51].  
Thermal ablation techniques presents similar limits regarding to: 
 The lack of pathological data, especially histological and molecular features of tumour, 
nodal status and margins of treatment: regarding the last issue, cryoablation is more 
attractive because the ablated zone correlates with the ice-ball image visualized by CT-
scan; this imply nonoptimal planning of adjuvant therapies  
 Local control of disease: tumours greater than 3 cm in diameter have a low likelihood of 
successful ablation with RF; MW ablation has shown promising rates of local control 
also for tumours until 5 cm; overall local tumour progression rate was reported to be 
50% after RF for c-I NSCLC, compared to 28.6% after surgery [52]; some studies indicate 
that combination of thermal ablation (more effective in the centre of tumour) and 
external beam radiotherapy (more effective at periphery of the lesion) could remarkably 
improve local control of disease [53] 
 Evaluation of treatment response and monitoring of recurrences is more challenging 
after thermal ablation, because both residual mass and ablation zone are present: 
inflammatory response to heat damage may be responsible of initial apparent increase 
in size of tumour; FDG uptake at PET scan, in addition to CT criteria, is useful to 
predict completeness of tumour ablation but it should not be performed before 3 
months to prevent false positives due to inflammatory response [54] 
 Complications: major complication (pneumothorax requiring chest tube drainage, air 
embolism and pulmonary abscess) are reported in about 8% of procedures, depending 
on tumour size and pulmonary reserve; minor complications as hemoptysis, fever, 
pleuritis with effusion, damages to phrenic or intercostals nerves are much more 
frequent (cumulative incidence: 50%) and may sometimes significantly impair quality 
of life of patients with poor baseline performance status [50] 
Regarding the last point, Tada and coll. reported that pulmonary function significantly 
decreased after RF, with FEV1 and VC at 1 and 3 months significantly lower than the 
baseline: predictive factor of major functional loss were severe pleuritis (at 1 and 3 month) 
and ablation of large volume of marginal parenchyma (at 3 months). Shrinkage of ablated 
zone during healing process may retract surrounding lung tissue, resulting in a decrease of 
alveoli compliance [55].  
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Indications to RF should therefore adequately determined for severely impaired patients as 
well as indications to surgery. 
A recent review based on medically inoperable, early-stage NSCLC patients reports an 
advantage in 5-years survival and local recurrence rates of patients treated with stereotactic 
RT versus those treated by RF, at the cost of more disabling and lasting complications 
(actinic pneumonia, fatigue) [56]. 
We can conclude that thermal ablation should be part of the armamentarium against lung 
cancer in a multidisciplinary setting: its undeniable advantages (single session treatment, 
feasibility in marginal patients, repeatability) make it not only an alternative to surgery (e.g.: 
multiple small nodules) but primarily a complementary treatment (e.g.: treatment of 
recurrences after surgery, persistence of local disease after RT). 
7. Take home messages 
Provided that marginal patients should be evaluated in multi-disciplinary setting and on 
individual basis, some concepts should be kept in mind in management of octogenarians 
affected by NSCLC. 
 Age above than 80 is neither a contraindication to operative treatment nor a routine 
indication for lesser resection; even octogenarians, with reduced life expectancy, dead 
of cancer rather than of comorbidities 
 The presence of comorbidities (cardio-respiratory in particular) predict increased 
operative risk. This support the hypothesis that the potential association between 
advancing age and operative mortality is a reflection of increased co-morbidity rather 
than age per se. 
 Even healthy octogenarians could have reduced organ function, resulting in low 
tolerance of postoperative major complications, which are fatal in a considerable 
percentages of patients. 
 Extended resections should be avoided in octogenarians: lesions in early stages and yet 
not resectable with a standard lobectomy should therefore preferably managed in non-
operative way. 
 Complete and accurate clinical staging is crucial since pathological stage is the only 
predictive factor affecting long term survival. Accurate preoperative clinical staging is 
imperative and in this respect, a more standard use of PET-TC appear to be necessary. 
In case of doubt, invasive staging with mediastinoscopy should be used in the process 
of selection of candidates for surgery to avoid unnecessary operative risk in poor 
prognosis patients. 
 Surgery remains to date the benchmark in terms of local control of disease and should 
therefore be preferred to radiation therapy and thermal ablation until future studies 
will eventually provide evidences of better risk/benefit ratio. Minimally invasive 
surgery promises to carry a benefit on postoperative outcome of elderly people 
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 Lung volume reduction criteria applied to lung surgery could move the limit of 
operability: in case of poor respiratory reserve, additional considerations should be 
made before excluding them from surgery, because ppoFEV1% is inaccurate in 
particular cases. These more compromised patients could benefit of a preoperative 
pulmonary rehabilitation program: in this way it could be possible to minimize the rate 
of minor postoperative complications that are probably related to 1st day FEV1% [57]. 
Lung volumes remodelling in fact takes at least some months to complete and 
favourable effects are not immediately available. 
The critical issue is then to define which octogenarians will have the best chance of avoiding 
complications and ultimately benefit in terms of long survival after pulmonary resection 
and which are medically inoperable.  
8. Conclusion 
Octogenarians with adequate organ function affected by potentially resectable lung cancer 
are worthy of curative treatments because life expectancy almost always exceed prognosis 
of disease. Octogenarian should be considered as a patient with higher possibility to  
have multiple comorbidities and or reduced organ function (even subclinical) and should 
have access to lung cancer services regardless of age. High accuracy is recommended in 
clinical staging and functional assessment in order to select healthy patients who  
could really benefit of lung surgery with acceptable operative risk and with  
acceptable postoperative QOL. Surgical therapy is nowadays well accepted for healthy 
octogenarians. In marginal patients, appropriate counselling can support physician to 
decide on case-by-case basis whether to favour QOL over survival or vice-versa (as 
usually in the younger patients). Such patients should ideally be enrolled in randomised 
trials to provide an evidence base. 
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